Chemical Control of FGF-2 Release for Promoting Calvarial Healing with Adipose Stem Cells*

Chemical control of protein secretion using a small molecule approach provides a powerful tool to optimize tissue engineering strategies by regulating the spatial and temporal dimensions that are exposed to a specific protein. We placed fibroblast growth factor 2 (FGF-2) under conditional control of a small molecule and demonstrated greater than 50-fold regulation of FGF-2 release as well as tunability, reversibility, and functionality in vitro. We then applied conditional control of FGF-2 secretion to a cell-based, skeletal tissue engineering construct consisting of adipose stem cells (ASCs) on a biomimetic scaffold to promote bone formation in a murine critical-sized calvarial defect model. ASCs are an easily harvested and abundant source of postnatal multipotent cells and have previously been demonstrated to regenerate bone in critical-sized defects. These results suggest that chemically controlled FGF-2 secretion can significantly increase bone formation by ASCs in vivo. This study represents a novel approach toward refining protein delivery for tissue engineering applications.

[1]  T. Wandless,et al.  A general chemical method to regulate protein stability in the mammalian central nervous system. , 2010, Chemistry & biology.

[2]  Min Zhang,et al.  Toward delivery of multiple growth factors in tissue engineering. , 2010, Biomaterials.

[3]  Wei Wang,et al.  In vivo restoration of full-thickness cartilage defects by poly(lactide-co-glycolide) sponges filled with fibrin gel, bone marrow mesenchymal stem cells and DNA complexes. , 2010, Biomaterials.

[4]  M. Longaker,et al.  Different endogenous threshold levels of Fibroblast Growth Factor-ligands determine the healing potential of frontal and parietal bones. , 2010, Bone.

[5]  J. Glowacki,et al.  Cell-free and cell-based approaches for bone regeneration , 2009, Nature Reviews Rheumatology.

[6]  Po-Chun Chang,et al.  Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical use. , 2009, Human gene therapy.

[7]  M. Nagata,et al.  A local bone anabolic effect of rhFGF2-impregnated gelatin hydrogel by promoting cell proliferation and coordinating osteoblastic differentiation. , 2009, Bone.

[8]  S. Cartmell.  Controlled release scaffolds for bone tissue engineering. , 2009, Journal of pharmaceutical sciences.

[9]  M. Longaker,et al.  Differential expression of specific FGF ligands and receptor isoforms during osteogenic differentiation of mouse Adipose-derived Stem Cells (mASCs) recapitulates the in vivo osteogenic pattern. , 2008, Gene.

[10]  C. Contag,et al.  Chemical control of protein stability and function in living mice , 2008, Nature Medicine.

[11]  M. Longaker,et al.  Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs). , 2008, Bone.

[12]  T. Wandless,et al.  A Directed Approach for Engineering Conditional Protein Stability Using Biologically Silent Small Molecules* , 2007, Journal of Biological Chemistry.

[13]  J. Tessmar,et al.  Matrices and scaffolds for protein delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[14]  Shin-Tai Chen,et al.  Modifications of the fibroblast growth factor‐2 gene led to a marked enhancement in secretion and stability of the recombinant fibroblast growth factor‐2 protein , 2007, Journal of cellular biochemistry.

[15]  L. Banaszynski,et al.  A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules , 2006, Cell.

[16]  M. Longaker,et al.  FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. , 2006, Tissue engineering.

[17]  I. Kalajzic,et al.  In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice. , 2006, Biochemical and biophysical research communications.

[18]  F. Guilak,et al.  Clonal analysis of the differentiation potential of human adipose‐derived adult stem cells , 2006, Journal of cellular physiology.

[19]  Christopher H Contag,et al.  Adipose-derived adult stromal cells heal critical-size mouse calvarial defects , 2004, Nature Biotechnology.

[20]  L. Chaudhary,et al.  Differential growth factor control of bone formation through osteoprogenitor differentiation. , 2004, Bone.

[21]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[22]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[23]  Su‐Li Cheng,et al.  Erk Is Essential for Growth, Differentiation, Integrin Expression, and Cell Function in Human Osteoblastic Cells* , 2001, The Journal of Biological Chemistry.

[24]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[25]  C. Basilico,et al.  Signaling by Fibroblast Growth Factors (Fgf) and Fibroblast Growth Factor Receptor 2 (Fgfr2)–Activating Mutations Blocks Mineralization and Induces Apoptosis in Osteoblasts , 2000, The Journal of cell biology.

[26]  M. Ito,et al.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. , 2000, The Journal of clinical investigation.

[27]  D. Ornitz,et al.  FGFs, heparan sulfate and FGFRs: complex interactions essential for development. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[28]  J. Poser,et al.  Potential Role of Fibroblast Growth Factor in Enhancement of Fracture Healing , 1998, Clinical orthopaedics and related research.

[29]  Hiroshi Fukuda,et al.  Recombinant Human Basic Fibroblast Growth Factor Accelerates Fracture Healing by Enhancing Callus Remodeling in Experimental Dog Tibial Fracture , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  P. Marie,et al.  The Effects of Fibroblast Growth Factor‐2 on Human Neonatal Calvaria Osteoblastic Cells Are Differentiation Stage Specific , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  D. Rifkin,et al.  Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor , 1990, The Journal of cell biology.

[32]  E. Canalis,et al.  Effects of basic fibroblast growth factor on bone formation in vitro. , 1988, The Journal of clinical investigation.

[33]  D. Moscatelli,et al.  High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.

[34]  J. Fiddes,et al.  Human basic fibroblast growth factor: nucleotide sequence and genomic organization. , 1986, The EMBO journal.

[35]  Yukihide Iwamoto,et al.  Effects of FGF-2 on metaphyseal fracture repair in rabbit tibiae , 2003, Journal of Bone and Mineral Metabolism.

[36]  A Nagy,et al.  Stem cell bioengineering. , 2001, Annual review of biomedical engineering.

[37]  G. Wesolowski,et al.  Effects of acidic and basic fibroblast growth factors on osteoblastic cells. , 1989, Connective tissue research.